Literature DB >> 9117383

Estrous cycle phase variations in visceromotor and cardiovascular responses to colonic distension in the anesthetized rat.

S Sapsed-Byrne1, D Ma, D Ridout, A Holdcroft.   

Abstract

Visceromotor and cardiovascular responses to colonic distension were measured in female rats, anesthetized with halothane in oxygen, in the proestrus, estrus, metestrus and diestrus phases of the estrous cycle. Ten rats were studied in each group and responses were measured at 5-min intervals for 60 min. A mixed model analysis of variance showed that there was no real change in either the visceral or cardiovascular response with time. There was a highly significant difference in visceromotor responses between the phases of the estrous cycle (P < 0.001). During the phase of proestrus the balloon pressure at which a response was triggered was much lower, with a mean value (95% confidence interval) of 18.7 (16.1, 21.8) mmHg, than the other phases with mean values (95% confidence interval) of 31.9 (27.4, 37.2) mmHg for estrus, 28.1 (24.2, 32.8) mmHg for metestrus, and 31.1 (26.7, 36.3) mmHg for diestrus. The mean arterial blood pressure increased in all groups (range 3.2, 5.4%) as a response to the stimulus, but there was no associated heart rate variability and no significant differences in cardiovascular changes between the groups (P = 0.6). The visceromotor responses measured during the phase of proestrus occurred at a significantly lower threshold than in the other phases of estrous.

Entities:  

Mesh:

Year:  1996        PMID: 9117383     DOI: 10.1016/s0006-8993(96)00989-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

1.  Spinal cord processing of cardiac nociception: are there sex differences between male and proestrous female rats?

Authors:  Janine M Little; Chao Qin; Jay P Farber; Robert D Foreman
Journal:  Brain Res       Date:  2011-07-23       Impact factor: 3.252

Review 2.  Membrane estrogen receptors acting through metabotropic glutamate receptors: an emerging mechanism of estrogen action in brain.

Authors:  Paul E Micevych; Paul G Mermelstein
Journal:  Mol Neurobiol       Date:  2008-08-02       Impact factor: 5.590

3.  Sex and hormonal variations in the development of at-level allodynia in a rat chronic spinal cord injury model.

Authors:  Charles H Hubscher; Jason D Fell; Daya S Gupta
Journal:  Neurosci Lett       Date:  2010-04-29       Impact factor: 3.046

Review 4.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

5.  Estrogen modulation of peripheral pain signal transduction: involvement of P2X(3) receptors.

Authors:  Bei Ma; Li-Hua Yu; Juan Fan; Binhai Cong; Ping He; Xin Ni; Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2011-01-06       Impact factor: 3.765

Review 6.  Gender differences and hormonal modulation in visceral pain.

Authors:  M M Heitkemper; M Jarrett
Journal:  Curr Pain Headache Rep       Date:  2001-02

7.  Inhibitory effect of estrogen receptor beta on P2X3 receptors during inflammation in rats.

Authors:  Qian Jiang; Wen-Xin Li; Jia-Run Sun; Tian-Tian Zhu; Juan Fan; Li-Hua Yu; Geoffrey Burnstock; Hua Yang; Bei Ma
Journal:  Purinergic Signal       Date:  2016-11-05       Impact factor: 3.765

8.  Menstrual cycle phase does not influence gender differences in experimental pain sensitivity.

Authors:  Rebecca R Klatzkin; Beth Mechlin; Susan S Girdler
Journal:  Eur J Pain       Date:  2009-02-12       Impact factor: 3.931

9.  Efficacy of Tramadol as a Sole Analgesic for Postoperative Pain in Male and Female Mice.

Authors:  A Marissa Wolfe; Lucy H Kennedy; Jane J Na; Jean A Nemzek-Hamlin
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-07       Impact factor: 1.232

Review 10.  Sex differences and hormonal modulation of deep tissue pain.

Authors:  Richard J Traub; Yaping Ji
Journal:  Front Neuroendocrinol       Date:  2013-07-17       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.